MEN1 and neoplasm: In a study from Hai et al. reporting on 20 clinically diagnosed index cases of MEN1, frequency of MEN1 mutation was only 11% in nine patients presenting with a combination of tumors of parathyroids and pituitary glands vs. a 63% frequency in eleven patients with other tumor combinations (22).